Libin Zou

471 total citations
12 papers, 324 citations indexed

About

Libin Zou is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Libin Zou has authored 12 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Libin Zou's work include RNA modifications and cancer (7 papers), RNA Research and Splicing (4 papers) and Circular RNAs in diseases (3 papers). Libin Zou is often cited by papers focused on RNA modifications and cancer (7 papers), RNA Research and Splicing (4 papers) and Circular RNAs in diseases (3 papers). Libin Zou collaborates with scholars based in China and Nepal. Libin Zou's co-authors include Taowei Yang, Xumin Zhou, Junqi Luo, Wenbin Chen, Shengren Cen, Kaihui Wu, Fangpeng Shu, Xiangming Mao, Daojun Lv and Yang Yu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cell Death and Disease and Pharmacological Research.

In The Last Decade

Libin Zou

10 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Libin Zou China	7	233	192	122	47	30	12	324
Junqi Luo China	8	255 1.1×	218 1.1×	125 1.0×	45 1.0×	32 1.1×	9	360
Shengren Cen China	6	202 0.9×	160 0.8×	119 1.0×	43 0.9×	26 0.9×	8	284
Zhou Yang China	7	214 0.9×	174 0.9×	113 0.9×	47 1.0×	20 0.7×	12	344
Le Tang China	7	186 0.8×	190 1.0×	60 0.5×	66 1.4×	21 0.7×	14	285
Qiangnu Zhang China	12	277 1.2×	217 1.1×	65 0.5×	50 1.1×	29 1.0×	24	372
Mingdong Liu China	7	203 0.9×	126 0.7×	98 0.8×	63 1.3×	23 0.8×	7	266
Guannan Shu China	12	320 1.4×	249 1.3×	93 0.8×	38 0.8×	23 0.8×	17	407
Jiantao Mo China	6	192 0.8×	156 0.8×	94 0.8×	40 0.9×	26 0.9×	14	283
Guoquan Huang China	9	269 1.2×	248 1.3×	157 1.3×	51 1.1×	17 0.6×	15	396
Juanfei Peng China	9	218 0.9×	160 0.8×	42 0.3×	58 1.2×	17 0.6×	13	285

Countries citing papers authored by Libin Zou

Since Specialization

Citations

This map shows the geographic impact of Libin Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libin Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libin Zou more than expected).

Fields of papers citing papers by Libin Zou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Libin Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libin Zou. The network helps show where Libin Zou may publish in the future.

Co-authorship network of co-authors of Libin Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Libin Zou. A scholar is included among the top collaborators of Libin Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Libin Zou. Libin Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Liu, Ji, Niraj Maskey, Yadong Guo, et al.. (2025). CircCNOT6L modulates alternative splicing of SLC7A11 via splicing factor SRSF2 to confer ferroptosis resistance and promote metastasis in prostate cancer. Experimental & Molecular Medicine. 57(9). 2106–2120. 2 indexed citations

Wang, Zhengshi, Haotian Chen, Yongqiang Liu, et al.. (2025). Gut microbiota, metabolites, and cytokines in relation to the risk of prostate cancer in the Asian population. Frontiers in Oncology. 14. 1466190–1466190.

Zou, Libin, Dan Huang, Liu Ji, et al.. (2025). USP21/YBX1/HIF1-α promotes the progression of prostate cancer. Journal of Translational Medicine. 23(1). 1164–1164.

Zou, Libin, Yang Yu, Yongqiang Liu, et al.. (2024). The role and mechanism of NAT10‐mediated ac4C modification in tumor development and progression. SHILAP Revista de lepidopterología. 5(12). e70026–e70026. 14 indexed citations

Liu, Ji, Libin Zou, Zhijin Zhang, et al.. (2024). Acetyltransferase NAT10 promotes an immunosuppressive microenvironment by modulating CD8+ T cell activity in prostate cancer. Molecular Biomedicine. 5(1). 67–67. 1 indexed citations

Zhang, Zhijin, Ji Liu, Yang Wu, et al.. (2024). The functions and mechanisms of RNA modification in prostate: Current status and future perspectives. Frontiers in Genetics. 15. 1380746–1380746. 2 indexed citations

Luo, Junqi, Taowei Yang, Jun Wu, et al.. (2023). Exosomal PGAM1 promotes prostate cancer angiogenesis and metastasis by interacting with ACTG1. Cell Death and Disease. 14(8). 40 indexed citations

Zou, Libin, Wenbin Chen, Xumin Zhou, et al.. (2022). N6-methyladenosine demethylase FTO suppressed prostate cancer progression by maintaining CLIC4 mRNA stability. Cell Death Discovery. 8(1). 184–184. 33 indexed citations

Zhou, Xumin, Libin Zou, Hangyu Liao, et al.. (2021). Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+ T cell-mediated ferroptosis in castration-resistant prostate cancer. Acta Pharmaceutica Sinica B. 12(2). 692–707. 78 indexed citations

10.

Tan, Xiao, Wenbin Chen, Daojun Lv, et al.. (2021). LncRNA SNHG1 and RNA binding protein hnRNPL form a complex and coregulate CDH1 to boost the growth and metastasis of prostate cancer. Cell Death and Disease. 12(2). 138–138. 40 indexed citations

11.

Chen, Wenbin, Shengren Cen, Xumin Zhou, et al.. (2021). Circular RNA CircNOLC1, Upregulated by NF-KappaB, Promotes the Progression of Prostate Cancer via miR-647/PAQR4 Axis. Frontiers in Cell and Developmental Biology. 8. 624764–624764. 41 indexed citations

12.

Zhou, Xumin, Libin Zou, Wenbin Chen, et al.. (2020). Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer. Pharmacological Research. 164. 105305–105305. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact